Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
CareDx Inc (NASDAQ:CDNA) Expected to Announce Quarterly Sales of $38.23 Million
05:14am, Monday, 27'th Apr 2020
Wall Street analysts expect CareDx Inc (NASDAQ:CDNA) to post sales of $38.23 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for CareDx’s earnings, w
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
CareDx (NASDAQ:CDNA) Given Buy Rating at HC Wainwright
06:28am, Sunday, 26'th Apr 2020
CareDx (NASDAQ:CDNA)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Friday, AnalystRatings.com reports. They currently have a $4
Head to Head Review: Anpac Bio-Medical Science (NASDAQ:ANPC) versus CareDx (NASDAQ:CDNA)
05:22am, Sunday, 26'th Apr 2020
Anpac Bio-Medical Science (NASDAQ:ANPC) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of thei
CareDx (CDNA) Receives a Buy from H.C. Wainwright
11:14am, Friday, 24'th Apr 2020
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx (CDNA) today and set a price target of $43.00. The company's shares closed last Thursday
CareDx (CDNA) Receives a Buy from H.C. Wainwright
11:14am, Friday, 24'th Apr 2020
H.C. Wainwright analyst
Yi Chen
reiterated a
Buy
rating on CareDx (
CDNA
–
Research Report
) today and set a price target of
$43.00
. The company’s shares closed last Thursday at $24.08.
According
CareDx: A Robust Transplant Diagnostics Pick For 2020
08:47pm, Thursday, 23'rd Apr 2020
CareDx is targeting the medically essential stem cell and organ transplant market. The company has a robust financial profile. Investors, however, should be awa
Earnings Preview: CareDx (CDNA) Q1 Earnings Expected to Decline
04:32pm, Thursday, 23'rd Apr 2020
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: CareDx (CDNA) Q1 Earnings Expected to Decline
04:32pm, Thursday, 23'rd Apr 2020
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance
11:00am, Thursday, 23'rd Apr 2020
SOUTH SAN FRANCISCO, Calif., April 23, 2020 -- CareDx, Inc. (Nasdaq: CDNA) and Johns Hopkins University, announced today the launch of the ALARM (AlloSure Lung Allograft Remote.
Fred Cohen Investor Profile: Portfolio & Exits | PitchBook
06:05pm, Wednesday, 22'nd Apr 2020
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Fred Cohen. Use the PitchBook Platform to explore the full profile.
CareDx Presents New Heart and Lung Transplant Data in Virtual Meetings
11:00am, Wednesday, 22'nd Apr 2020
SOUTH SAN FRANCISCO, Calif., April 22, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
CareDx Presents New Heart and Lung Transplant Data in Virtual Meetings
11:00am, Wednesday, 22'nd Apr 2020
Leading transplant clinicians to present ten ISHLT accepted abstracts
